Drug intelligence / Profile preview

Kriminol

Development stage: Unknown
Lead developer: Vyas Pharmaceuticals
Administration: Oral

Overview

Kriminol is an Ayurvedic proprietary formulation developed and manufactured by Vyas Pharmaceuticals. Available in both tablet and syrup forms, it is traditionally used to treat various types of intestinal worm infestations, including tapeworms, threadworms, roundworms, whipworms, hookworms, and strongyloides. The formulation is composed of a blend of traditional Ayurvedic herbs, primarily Vidanga (Embelia ribes), Kalijiri (Centratherum anthelminticum), Palas beej (Butea monosperma), Haritaki (Terminalia chebula), Nisoth (Operculina turpethum), Saunf (Foeniculum vulgare), and Ajmoda (Apium graveolens). In addition to its anthelmintic properties, Kriminol is used to stimulate appetite, improve digestion, and support overall gastrointestinal health.

Brand names: Kriminol
Other names: Kriminol SyrupKriminol Tablet

Beyond the preview

Go deeper on Kriminol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kriminol.

Explore the full profile